Regulatory barriers often inhibit the timely delivery of cutting-edge cellular therapeutics to patients burdened with chronic diseases and disabilities. The Bipartisan Policy Center and Regenerative Medicine Foundation are trying to change this by recommending that Congress support a federally funded registry for regenerative cell therapies.
This registry would help share the outcomes of potentially curative therapies so that the general public, clinicians, and researchers are able to learn from shared data. This would help inform decision-making and ultimately help accelerate the development and delivery of safe and effective cures for patients in the United States.
Check out the full article here:
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.